The upside case is real because Amprius already has paying customers, improving margins, and a product that matters where endurance and weight are mission-critical. I still stop short of hypergrowth because value creation depends on partner manufacturing control,
qualification cycles, and holding premium pricing as volumes rise. This supports a strong but not extreme 5-year outcome.